Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clodronate intramuscular dosing frequency study in postmenopausal osteoporosis
2010-022060-13Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of clodronate in postmenopausal osteoporosis (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Lumbar bone mineral density after 1 year. Started Jun 2011; status: completed.
02
Drugs
clodronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2010-022060-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022060-13.